Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
- Status
- TERMINATED
- Phase
- PHASE2
Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Optimizing PTCy Dose and Timing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
- Status
- COMPLETED
- Phase
- PHASE2
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
- Status
- TERMINATED
- Phase
- PHASE3
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL
- Status
- COMPLETED
- Phase
- PHASE1
Compassionate Use Re-Infusion of ATLCAR.CD30
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2